Teladoc Health (NYSE:TDOC) Stock Rating Reaffirmed by Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of Teladoc Health (NYSE:TDOC - Free Report) in a research note released on Friday, Benzinga reports.

Several other equities analysts have also issued reports on TDOC. Truist Financial dropped their price objective on Teladoc Health from $23.00 to $17.00 and set a hold rating on the stock in a report on Wednesday, March 6th. Canaccord Genuity Group reduced their price objective on Teladoc Health from $34.00 to $28.00 and set a buy rating for the company in a research note on Wednesday, February 21st. Barclays lowered their target price on shares of Teladoc Health from $26.00 to $25.00 and set an overweight rating on the stock in a research report on Wednesday, February 21st. Piper Sandler reduced their price target on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating for the company in a research report on Wednesday, February 21st. Finally, SVB Leerink assumed coverage on shares of Teladoc Health in a research report on Monday, February 26th. They set a market perform rating and a $17.00 price objective on the stock. Eleven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of Hold and a consensus target price of $19.67.

Teladoc Health Stock Down 2.4 %

Shares of NYSE TDOC traded down $0.32 during midday trading on Friday, hitting $13.01. 7,695,552 shares of the company's stock were exchanged, compared to its average volume of 4,798,968. The firm's fifty day simple moving average is $15.17 and its 200-day simple moving average is $17.80. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. The company has a market cap of $2.20 billion, a PE ratio of -9.74 and a beta of 0.94. Teladoc Health has a twelve month low of $12.65 and a twelve month high of $30.41.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million for the quarter, compared to analysts' expectations of $637.31 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.37) EPS. Research analysts predict that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other news, CTO Nikolaos P. Nanis sold 2,866 shares of the business's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $41,614.32. Following the sale, the chief technology officer now owns 69,850 shares of the company's stock, valued at approximately $1,014,222. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, COO Michael Willem Waters sold 4,523 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $86,751.14. Following the sale, the chief operating officer now directly owns 38,570 shares in the company, valued at $739,772.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Nikolaos P. Nanis sold 2,866 shares of the company's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $41,614.32. Following the completion of the sale, the chief technology officer now directly owns 69,850 shares in the company, valued at approximately $1,014,222. The disclosure for this sale can be found here. Insiders sold 135,441 shares of company stock worth $2,038,251 over the last 90 days. Company insiders own 1.63% of the company's stock.

Institutional Trading of Teladoc Health

Institutional investors and hedge funds have recently made changes to their positions in the stock. ARK Investment Management LLC increased its stake in Teladoc Health by 4.5% in the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider's stock valued at $457,389,000 after purchasing an additional 912,692 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock valued at $377,451,000 after acquiring an additional 1,855,480 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Teladoc Health by 25.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock worth $82,636,000 after acquiring an additional 767,999 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Teladoc Health by 6.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider's stock valued at $35,646,000 after buying an additional 104,531 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Teladoc Health by 9.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 658,435 shares of the health services provider's stock worth $12,240,000 after buying an additional 57,989 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.